Introduction
The Lewis blood group antigens Lewis a (Le a ) and Lewis b (Le b ) are carbohydrate antigens related to the ABO blood group antigen that are synthesized in epithelial tissues and adsorbed to the surface of red blood cells; these antigens can also be detected in saliva and other secretions, as well as on cells of mucosal epithelia [1] [2] [3] .This system was first described in 1946 by Mourant when anti-Lea was found; subsequently anti-Le b was reported by Anderson in 1948 1, 2 . The term Lewis refers to the family name of individuals suffering from a red cell incompatibility problem that lead to the discovering of this blood group 3 . The antigens are poorly developed at birth and the phenotype of red cells from cord blood is usually Le (a-b-). Subsequently Lea develops first, followed by Le b when the relevant Lewis and secretor genes are present. A definite adult Lewis phenotype
Results
Record revealed variable age of 350 study subjects, from 1 to 75 years, including 50 children (14.3%) under 5 years of age and 177 male adults (50.6%), however, Lewis antibody was present in only 178 (50.8%) cases. Moreover among Lewis phenotypes, of positive cases, the Le(a-b+) was found in 124 (35.3%) cases, Le(a+ b) in 53 (15.1%) cases and the phenotype Le(a+ b+) in one case (0.3%) only. The cases negative for Lewis antibody represent the Le (a-b-) phenotype in 172 (49.2%) subjects (Table-I ). The presence of Lewis antibodies in relation to ABO system was shown in Table 2 . Among the Lewis antibody positive cases, antiLeb was predominant (69.7%) followed by anti-Lea (29.8%). and only one case had anti-Le a +b (0.6%). Table- II also showed, the anti-Le b was more common (75%) in Lewis positive ABO groups, predominantly in "O" group individuals .Frequency pattern of anti-Leb in association with ABO blood group system was O>A> AB>B whereas, pattern of anti-Lea was B>AB>A>O with predominance in B group (37.7%). Agglutination of red cells in presence of anti-Lewis antibodies exhibited a characteristic stringy appearance resembling chains of cells when observed microscopically (Figure 1 ), while incompatible cross match showed an area of irregular agglutination or rouleaux of red cells (Figure 2 ). [7] [8] [9] . It is shown that the presence of Le antibodies may cause some difficulties in cross-match techniques in blood transfusion 6, 10 . The aim of this study was to detect the presence of Lewis antibodies and their phenotype, compare the agglutination patterns appearing in routine blood testing for cross matching and also ABO blood group among samples having Lewis antibodies. Randomly selected blood samples were taken either from patients requesting blood group and cross match as well as from voluntary blood donors who were screened for safe blood transfusion. The tests were performed using saline agglutination (Hemagglutination) technique at room temperature using monoclonal antibodies available commercially (BIOSCOT LIMITED, Livingston, UK). Each step of the test procedure was followed meticulously as per manufacturer's instruction. Agglutination of red cells occurs in two stages. The first stage consists of the binding of antibody to antigens on the red cells (sensitization) and the second stage involves agglutination of sensitized red cells. Reagent activity was confirmed with known positive and negative cells (Organon Teknika, Panel-10 cells). In addition, auto-agglutination using patients own cells and serum was set up side by side in each batch as a control. The results of the tests were read macroscopically and confirmed microscopically. Results were then analyzed to determine the proportions of Lewis antigens and its relative frequency relating to ABO and Rh blood groups. 12, 13 . RBC expressing the Le (a+b+) phenotype in infants eventually will be converted into Le (a-b+) expression by two years of age so, in our study we found, 49.1% were Le (a-b-) 11, 17 . The higher frequency (49.1%) of phenotype Le (a-b-) in our study may be attributed to inclusion of children less than 5 years, whereas, in a Dhaka based study on children with ETEC diarrhea, 59 % were Le (a-b+), 26% were of Le (a+b-) phenotype and 15% had a Le (a-b-) blood group phenotype as determined by both blood and saliva tests which has similar phenotypic pattern with us, whereas, the percentage of the Le (a-b+) phenotype in our study (35.4% ) was much lower than that in Caucasians (~70-80%) but similar to the Lewis antigen distribution in adult Indians and in African population 11, 17, 18 . Lewis antibodies always bind complement and convenient to detect by indirect antibody Test (IAT), using a reagent containing anti-complement and more enhanced using Low ionic strength (LISS) or by enzyme treated cells 14 . Study showed there is higher frequency of the phenotype Le (a-b-) in patients with cancer of the bladder seems to be due to the conversion of Le-positive to Le-negative with advanced disease. Donors of anti-Le a belong more frequently to groups A, B or AB shows weakly expressed Lewis antigen, however, the risk of haemolytic transfusion reaction may occur if, Le (a+) red cells of group O, which have more Lewis antigens than A or B cells, has been selected for a patient whose serum contains potent anti-Le a . Thus, Lewis antibodies, particularly anti-Lea can cause rapid destruction of small volume of Le (a+) red cells and results positive indirect anti-globulin test (IAT) with anti-complement at 37 0 C, whereas, some anti-Leb sera fail to react with A1 cells although they react strongly with cells of group O or A 2. In our study we found that in group O study subjects anti-Lea was 25% and anti-Leb was 75%. In countries in South-East Asia, Lewis antibodies may be more potent than Europeans to cause severe haemolytic transfusion reactions [12] [13] [14] . Study also reported presence of auto-anti-Lea in a multi-transfused Le (a-b+) patient with carcinoma of the oesophagus where, the patient's own red calls partially adsorbed the antibody 14 . 
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Discussion
The Lewis antigen system has three different phenotypes; Le(a+b-) (these individuals have the nonsecretor phenotype); Le(a-b+), in which a fucosyltransferase converts Lea to Leb (these individuals have the secretor phenotype); or Le(a-b-), in which there is a failure to express either antigen (these individuals can be either secretors or non-secretors) 11 so, the phenotypes Le(a-b+) and Le (a+b+) are secretor groups 12 . In our study we found that, the Lewis antigens (Le a and Le b ) are rarely of clinical significance due to presence of abundant Lewis substances (Le) in serum, which may neutralize the antibodies in vitro during the cross match or in vivo during transfusion and the gradual elution of Lewis antigens from the donor red cells 9 . However; Lewis antibodies have the potential to be clinically significant when it causes in vitro hemolysis during serological testing. Once these in vitro hemolytic antibodies are detected, they should be considered clinically relevant, and antigen-negative blood should be selected for transfusion 10, 11 . Potent Lewis antibodies will sensitize red cells to agglutination by anti-IgM but very seldom to agglutination by anti-IgG. Study showed the phenotype Le (a-b-) is substantially commoner in However, least difficulty caused by Lewis antibodies in blood transfusion may be partially due to effect of Lewis substances in the donor 's plasma which neutralizes corresponding antibodies in the recipient's plasma and partially due to the chameleon-like behavior of red cells which is within a few days of transfusion assume the phenotype of the recipient 1, 14 . Cross match is done to ensure the safety of the recipient by detecting the complete, incomplete or irregular antibodies present in the donor cells or serum. Usually an area of irregular agglutination or rouleaux of red cells leads to confusion in interpreting compatibility test whether it is really a mismatch or due to presence of an artifact. A mismatch may occur due to an error in grouping or due to presence of atypical or irregular antibodies in the patient or donor's serum. Presence of strong agglutinins in donor and/or recipient serum might pose difficulty in cross matching to laboratory professionals, especially when the patient requires immediate and frequent multiple blood transfusions 1, 14 . So in testing suspected Lewis antibodies, the use of fresh cells and short incubation period with skilled and experienced professionalism is needed to detect agglutination reactions and to avoid any untoward reactions.
Conclusion
Our study showed Lewis antibody in 50.8 % cases and as we know presence of strong agglutinins in donor and/or recipient serum might pose difficulty in cross matching, detection and identification of irregular antibodies are of clinical importance to the patients requiring multiple transfusions who already possess atypical or irregular antibodies (alloimmunization).
